CStone Pharmaceuticals (HKG:2616)
Hong Kong · Delayed Price · Currency is HKD 6.65
+0.22 (3.42%)
At close: Mar 6, 2026
CStone Pharmaceuticals Market Cap
CStone Pharmaceuticals has a market cap or net worth of 9.79 billion as of March 6, 2026. Its market cap has increased by 201.95% in one year.
Market Cap
9.79B
Enterprise Value
9.46B
Revenue
221.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.65
Market Cap Chart
Since February 26, 2019, CStone Pharmaceuticals's market cap has decreased from 12.65B to 9.79B, a decrease of -22.63%. That is a compound annual growth rate of -3.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 9.79B | 26.19% |
| Dec 31, 2025 | 7.76B | 164.29% |
| Dec 31, 2024 | 2.94B | 1.52% |
| Dec 29, 2023 | 2.89B | -47.58% |
| Dec 30, 2022 | 5.52B | -42.71% |
| Dec 31, 2021 | 9.63B | -16.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Keymed Biosciences | 13.65B |
| Everest Medicines | 12.04B |
| Guangzhou Innogen Pharmaceutical Group | 10.18B |
| Nanjing Leads Biolabs | 9.95B |
| Shanghai Haohai Biological Technology | 9.85B |
| HBM Holdings | 9.58B |
| CK Life Sciences Int'l., (Holdings) | 7.59B |
| Alphamab Oncology | 7.42B |